SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
SkyCell has raised $59.0M in total funding. The most recent round was Series D. The last funding was announced in June 2024.
SkyCell's investors include M&G Investments, Shuaa Capital psc, MVM Life Science Partners, Lazard Asset Management, BCGE.
SkyCell is headquartered in Zurich, Switzerland.
SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
SkyCell is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SkyCell — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/skycell. Accessed September 16, 2026.
VCBacked. (2024). SkyCell — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/skycell
{{cite web |title=SkyCell — Funding & Investors |url=https://www.vcbacked.co/company/skycell |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated